BackPAVmed- Warrants (29/01/2022) Overview

PAVmed- Warrants (29/01/2022) Other Current Assets

Track PAVmed- Warrants (29/01/2022)'s other current assets ($1.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.06M
↓ 99.93% YoYΔ $-1.48B vs prior year quarter

Peer average / median

Loading

PAVmed- Warrants (29/01/2022) Other Current Assets History

Loading

PAVmed- Warrants (29/01/2022) vs. peers: Other Current Assets Comparison

Loading

PAVmed- Warrants (29/01/2022) Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PAVmed- Warrants (29/01/2022) (PAVMW) FAQ

As of the most recent data (June 2026), PAVMW shows a other current assets of $1.1M. That compares with $1.5B in the prior-year period — down 99.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PAVMW's other current assets is now $1.1M (was $1.5B) — a 99.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PAVmed- Warrants (29/01/2022) is outperforming or lagging.

Tracking PAVMW's other current assets over time shows whether PAVmed- Warrants (29/01/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $1.5B in the prior-year period — down 99.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has PAVmed- Warrants (29/01/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.1M) with ownership activity and broader fundamentals.

PAVmed- Warrants (29/01/2022)'s other current assets is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.